603 In an 18-month proof-of-concept open-label randomized study, no statistically significant treatment group differences in the prevalence of confirmed clinical neuropathy (CCN), IENFD, and nerve conductions were observed
EatingWell / Registered Dietitian Expert Review
There are similar instances of decrease in SCFAs producing microbiota in the gut in glioma patients which could be employed to understand the glioma progression
When evaluating lithium batteries for high-power applications, one parameter appears repeatedly on datasheets: C rating
doi:10.1016/j.cgh.2015.04.176
GLP-1 receptors also hold promise for people with MASLD, a common chronic liver disease linked to increased risk of type 2 diabetes mellitus, CKD, or other cardiometabolic complications [98-100]